Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

Support Groups and Counseling: Both military bases and VA hospitals often host support groups for individuals dealing with ...

And while I’m not happy to be part of this club, I’m glad to have this knowledge. It helped me understand that I’m a cancer ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

The past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been ...

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four main categories and highlighting possible new therapeutic targets.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential ...

Wolpin’s team used AI to find patterns in over nine million patients, looking at medical records, family history and genetic ...

Scientists discovered the cancer-causing cell with a genetic mutation that causes a common variant of breast cancer first emerges in patients around the age of puberty. A team of researchers ...

Breast cancer in men can be misdiagnosed or overlooked because it’s so rare, but early detection can be lifesaving.